发明名称 Hydrophilic/lipophilic polymeric matrix dosage formulation
摘要 An oral dosage form comprising a pharmaceutical tablet of one or more layers, one of which carries a biologically active substance; the formulation of said tablet includes different percentages of hydrophilic and lipophilic polymeric materials, and adjuvant substances. The tablets of the present invention show a release rate which is independent from the amounts of active substance present in the tablet.
申请公布号 US7927624(B2) 申请公布日期 2011.04.19
申请号 US20070717502 申请日期 2007.03.12
申请人 JAGOTEC AG 发明人 VERGNAULT GUY;GRENIER PASCAL;MAGGI LAURETTA;CONTE UBALDO
分类号 A61K9/24;A61K31/40;A61K9/20;A61K9/22;A61K31/138;A61K31/165;A61K31/198;A61K31/404;A61K31/4045;A61K31/506;A61K31/517;A61K31/5377;A61K31/585;A61K38/55;A61K47/10;A61K47/12;A61K47/14;A61K47/32;A61K47/34;A61K47/36;A61K47/38;A61K47/40;A61K47/44;A61P7/10;A61P9/00;A61P9/04;A61P9/06;A61P9/08;A61P9/12;A61P25/02;A61P25/16;A61P25/28 主分类号 A61K9/24
代理机构 代理人
主权项
地址